CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-12-31 | Lafond Kevin G Vice Pres., Treasurer, & CAO | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2013-12-31 | Fowler Wyche Director | Grant or award | +18,818 | 108,864 | ||
| 2013-12-31 | Fowler Wyche Director | Shares withheld for taxes | −2,339 | 106,525 | ||
| 2013-12-31 | CANNON JAMES ANTHONY Director | Grant or award | +18,818 | 294,976 | ||
| 2013-12-31 | BRENNAN MURRAY Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2013-12-31 | BELBEL CAESAR J EVP, CLO, and Secretary | Shares withheld for taxes | −7,193 | $4.34 | $31K | 45,594 |
| 2013-12-31 | BELBEL CAESAR J EVP, CLO, and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2013-12-31 | KIRK RANDAL J Director | Grant or award | +18,818 | 78,941 | ||
| 2013-10-29 | KIRK RANDAL J Director | Purchase | +2,857,143 | $3.50 | $10.0M | 16,390,305 |
| 2013-06-27 | Lafond Kevin G Vice Pres., Treasurer, & CAO | Grant or award · Employee Stock Option (Right to Buy) | +82,500 | 82,500 | ||
| 2013-06-27 | BELBEL CAESAR J EVP, CLO, and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2013-06-27 | LEWIS JONATHAN CEO | Grant or award · Employee Stock Option (Right to Buy) | +330,000 | 330,000 | ||
| 2013-05-08 | Amello Jason Executive Vice President & CFO | Shares withheld for taxes | −2,623 | $1.65 | $4K | 22,377 |
| 2013-02-22 | BELBEL CAESAR J EVP, CLO, and Secretary | Shares withheld for taxes | −5,400 | $4.50 | $24K | 52,787 |
| 2012-12-31 | Amello Jason Executive Vice President & CFO | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2012-12-31 | Youssoufian Hagop President of R&D and CMO | Shares withheld for taxes | −6,919 | $4.21 | $29K | 92,721 |
| 2012-12-31 | Youssoufian Hagop President of R&D and CMO | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2012-12-31 | WEISER MICHAEL Director | Grant or award | +17,546 | 178,790 | ||
| 2012-12-31 | WEISER MICHAEL Director | Shares withheld for taxes | −1,904 | $4.21 | $8K | 176,886 |
| 2012-12-31 | MCINERNEY TIMOTHY Director | Grant or award | +17,546 | 252,760 |
Page 22 of 25 · 493 trades